RTW Biotech Opportunities Ltd

RTWG

GG00BKTRRM22

Closed End Funds

Market Closed - London S.E. Other stock markets 09:05:22 11/06/2024 pm IST			5-day change	1st Jan Change
1.43 ^USD	+0.70%		+0.70%	+1.96%

11:56am	RTW Biotech portfolio company to sell subsidiary for USD1.25 billion	AN
30/05	RTW Biotech Opportunities Ltd commences an Equity Buyback Plan for 57,844,388 shares, representing 14.99% of its issued share capital, under the authorization approved on May 16, 2024.	CI

RTW Venture Fund Limited will Change its Name to RTW Biotech Opportunities Ltd

June 22, 2023 at 09:30 am IST

Effective June 22, 2023, RTW Venture Fund Limited will change its name to RTW Biotech Opportunities Ltd.

Latest news about RTW Biotech Opportunities Ltd

RTW Biotech portfolio company to sell subsidiary for USD1.25 billion	03:26pm	AN
RTW Biotech Opportunities Ltd commences an Equity Buyback Plan for 57,844,388 shares, representing 14.99% of its issued share capital, under the authorization approved on May 16, 2024.	30/05	CI
RTW Biotech Opportunities Ltd?s Equity Buyback announced on July 20, 2023, has expired.	16/05	CI
Future Metals celebrates state government grant	16/05	AN
RTW Biotech Opportunities Invests in Lycia Therapeutics $106 Million Funding Round	15/05	MT
RTW Biotech invests in cell and gene therapy company Obsidian	05/04	AN
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises	02/04	AN
RTW Biotech Opportunities Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Franchise Brands sets targets, Cindrigo agrees loan	21/02	AN
RTW Biotech Opportunities NAV increases 2.5% in January	15/02	AN
RTW Biotech Opportunities Completes Arix Bioscience Acquisition	13/02	MT
Katoro Gold launches fundraising, eyes board shake-up	13/02	AN
Arix Bioscience's Asset Sale to RTW Biotech Takes Effect	12/02	MT
Arix Bioscience shares suspended ahead of RTW takeover	12/02	AN
Arix Bioscience Shares to be Suspended on London Exchange Amid Acquisition	12/02	MT
Apax opts against lifting offer; DCI enters loan deal	10/02	AN
Arix Bioscience Shareholders Approve Asset Sale to RTW Biotech	29/01	MT
Arix Bioscience Gains UK Regulatory Approval for Sale to RTW Biotech	23/01	MT
RTW Biotech completes Arix investment in takeover run-up	22/01	AN
RTW Biotech Buys Minority Stake in Arix Bioscience to Support Planned Takeover	22/01	MT
RTW Biotech's manager invests USD127 million in Ji Xing	11/01	AN
RTW Biotech Opportunities invests USD127 million in investee Ji Xing	08/01	AN
Microsaic in funding talks; Jarvis says no payout	14/11	AN
FTSE 100 Closes Up 0.28% as Interest Rate Rise Fears Start to Ease	01/11	DJ
RTW Biotech agrees "immediately accretive" Arix Bioscience takeover	01/11	AN

Chart RTW Biotech Opportunities Ltd

Duration

Period

More charts

RTW Biotech Opportunities Ltd is a Guernsey-based focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. The Company invests in companies developing therapies and technologies that can significantly improve patients' lives. The Company seeks to achieve its investment objective by leveraging the Investment Manager's data driven pipeline of assets to invest in life sciences companies across various therapeutic categories and product types (including genetic medicines, biologics, traditional modalities, such as small molecule pharmaceuticals and antibodies, and medical devices). It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life. The Company's portfolio is managed by RTW Investments, LP.

Sector

Closed End Funds

Calendar

12/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Closed End Funds

	1st Jan change	Capi.
RTW BIOTECH OPPORTUNITIES LTD	+1.96%	477M
ARES CAPITAL CORPORATION	+6.99%	13.22B
PERSHING SQUARE HOLDINGS, LTD.	+16.16%	9.95B
FS KKR CAPITAL CORP.	+2.73%	5.77B
PIMCO DYNAMIC INCOME FUND	+7.91%	5.31B
SPROTT PHYSICAL SILVER TRUST	+21.84%	4.86B
SPROTT PHYSICAL URANIUM TRUST FUND	-10.05%	4.74B
SPROTT PHYSICAL GOLD AND SILVER TRUST	+19.20%	4.53B
MACQUARIE KOREA INFRASTRUCTURE FUND	+1.53%	4B
3I INFRASTRUCTURE PLC	+2.02%	3.91B